How much does semaglutide cost in 2026? Every pathway compared
Semaglutide — the active molecule in Wegovy, Ozempic, and compounded programs — has more price tiers than any other weight management drug. The gap between the cheapest and most expensive option exceeds $1,000 a month. Which number applies to you depends on which form, which pathway, and what your insurance covers.
Semaglutide's monthly cost spans more than $1,200 depending on the pathway: at the high end, retail Wegovy with no program runs about $1,350/mo; at the low end, compounded semaglutide through telehealth starts around $150/mo all-in. Brand self-pay (NovoCare's Wegovy and Ozempic programs) and insurance-covered pricing land in between — every pathway, with real numbers, is broken down below.
On this page
- What you'll actually pay
- Three forms of semaglutide — three very different prices
- Compounded semaglutide: $150–$297/mo — the cheapest option
- Brand Wegovy cost: retail vs. NovoCare vs. insurance
- Ozempic cost: diabetes drug, weight use, complex pricing
- Why semaglutide matters for women in perimenopause
- Frequently asked questions
What you'll actually pay
We may earn a commission if you sign up through a link. It never affects the ranking. How we review
All-in: medication, consult, shipping. Compounded 503A. Starter dose at lower end; confirm full titration ladder.
See Fridays's prices$99/mo medication (flat at any dose) + $79/mo membership. Obesity-medicine physicians.
See Mochi Health's pricesVisits, medication, shipping bundled. Oral or injectable. No long-term contract.
See Henry Meds's pricesShow the other 5 providers
FDA-approved Wegovy, self-pay direct from Novo Nordisk: pill $149/mo (1.5 mg), $199 (4 mg), $299 (9 and 25 mg); pen $199/mo for the first two fills (through Dec 31, 2026), then $349–$399/mo by dose.
See NovoCare's pricesNovoCare savings card caps copay at $25/mo for eligible commercially insured patients. Cannot be combined with Medicare/Medicaid.
See Wegovy's pricesOzempic for diabetes (off-label for weight loss) via NovoCare self-pay. Dose-dependent pricing.
See NovoCare's pricesBrand Ozempic at retail pharmacy with GoodRx coupon. Primarily for T2D; off-label for weight loss.
See Ozempic's pricesCash price at retail without any program. Always check NovoCare or GoodRx first.
See Wegovy's pricesThree forms of semaglutide — three very different prices
Semaglutide is one molecule with three commercial forms: Wegovy (FDA-approved for obesity, injection), Ozempic (FDA-approved for type 2 diabetes, injection, widely used off-label for weight), and compounded semaglutide (pharmacy-mixed, available through 503A pharmacies via telehealth). Each has a distinct price structure, access pathway, and risk profile. Understanding which you're looking at — and why — is the first step.
Compounded semaglutide: $150–$297/mo — the cheapest option
Compounded semaglutide dispensed through 503A pharmacies via telehealth is consistently the cheapest semaglutide option for cash-pay patients. Prices range from about $150 to $297 a month depending on provider, dose, and how membership or visit fees are billed. The medication is pharmacy-mixed rather than an FDA-approved finished product.
The legal landscape has narrowed since the FDA declared the semaglutide shortage resolved. What remains is a 503A individual-patient pathway: a compounding pharmacy dispensing for a specific patient with a documented clinical need. Most major telehealth providers operate this way today. Confirm with any provider how they document and source compounded semaglutide before enrolling.
Fridays — $150–$249/mo all-in
Fridays offers the lowest verified compounded semaglutide starting price — approximately $150 a month for the starter dose, covering medication, clinical consult, and shipping in one price. Prices rise through the titration schedule. Ask for the full dose ladder before committing.
Mochi Health — flat medication fee plus membership
Mochi charges $99 a month for semaglutide at any dose — dose-flat pricing that doesn't rise with each titration step. The separate $79 monthly membership brings the all-in total to about $178. For patients who anticipate a long titration or who need to hold at a higher dose, the flat medication fee can outperform a lower-headlined competitor whose per-dose price climbs.
Henry Meds — bundled $197–$297/mo
Henry Meds bundles everything — visits, medication, supplies, shipping — into a single monthly price that varies with dose. Compounded semaglutide runs about $197 at starter doses and up to $297 at higher doses. No long-term commitment required.
Brand Wegovy cost: retail vs. NovoCare vs. insurance
Wegovy's retail list price is approximately $1,350 a month — the number you'll see on the package insert and at the pharmacy counter without any program. Almost no one actually pays this. The real price depends on which access route you use.
With commercial insurance + NovoCare savings card: $25/mo
If your commercial insurance covers Wegovy and you enroll in the NovoCare savings card, your monthly out-of-pocket is capped at $25. This is the lowest-cost pathway for Wegovy — significantly cheaper than any compounded option. The qualifier is real commercial insurance coverage for Wegovy, which requires the right plan, the right BMI, and often prior authorization. Cannot be used with Medicare or Medicaid. Medicare members have a separate route: the Medicare GLP-1 Bridge pilot prices any Wegovy dose at a flat $50 a month from July 1, 2026 through December 31, 2027 for members who meet its BMI criteria.
Without insurance: NovoCare self-pay from $149 (pill) or $199 (pen)
Novo Nordisk's direct self-pay program now covers both Wegovy formats: the pill at $149 a month at 1.5 mg, $199 at 4 mg and $299 at the 9 and 25 mg maintenance doses, and the pen at $199 a month for your first two fills (through December 31, 2026), then $349 a month at standard doses or $399 at the 7.2 mg HD strength. This is FDA-approved, brand-name Wegovy shipped from the NovoCare pharmacy — not compounded — and GoodRx now surfaces the same Novo cash price at retail pharmacies rather than a separate discount.
Ozempic cost: diabetes drug, weight use, complex pricing
Ozempic (semaglutide injection) is FDA-approved for type 2 diabetes and commonly used off-label for weight loss. Its price structure differs from Wegovy because coverage is tied to a diabetes diagnosis, not obesity.
Retail pharmacy Ozempic without any discount runs roughly $900–$1,000 a month. With a GoodRx coupon, the range drops to approximately $700–$800 depending on dose and pharmacy. Novo Nordisk also has a NovoCare self-pay program for Ozempic, priced at $349–$499 a month depending on dose. For women with a type 2 diabetes diagnosis, insurance coverage of Ozempic is more reliably available than Wegovy coverage — confirm with your plan.
Why semaglutide matters for women in perimenopause
The weight changes that often accompany perimenopause are hormonally driven: estrogen decline shifts fat toward the abdomen, worsens insulin sensitivity, and disrupts the GLP-1 and leptin pathways that regulate appetite. Semaglutide addresses these mechanisms directly — which is why obesity-medicine physicians increasingly see GLP-1 medications as well-matched to the perimenopausal metabolic environment, not just as generic weight loss drugs.
Frequently asked questions
How much does semaglutide cost per month in 2026?+–
It depends on which form and pathway. Compounded semaglutide through a telehealth provider starts around $150 a month all-in. Brand Wegovy through NovoCare self-pay runs $149–$299 a month for the pill by dose, or $199 introductory then $349–$399 for the pen. With commercial insurance and the NovoCare savings card, Wegovy costs $25 a month. Ozempic retail runs $900–$1,000/mo; NovoCare Ozempic program is $349–$499/mo. Retail pharmacy without any discount for Wegovy is about $1,350/mo.
What is the difference between Wegovy and Ozempic cost?+–
They contain the same molecule (semaglutide) at different doses and indications. Wegovy is approved for obesity; Ozempic is approved for type 2 diabetes. Retail prices are similar ($900–$1,350/mo), but insurance coverage differs significantly: Wegovy coverage requires an obesity benefit; Ozempic coverage typically requires a T2D diagnosis. NovoCare offers self-pay programs for both. Compounded semaglutide ($150–$297/mo) bypasses both brand-name products.
Is compounded semaglutide safe and legal?+–
It can be obtained legally through a 503A individual-patient pathway when a licensed physician prescribes it for a patient with documented clinical need. Quality varies by compounding pharmacy — look for programs that use PCAB-accredited pharmacies. On safety: compounded semaglutide contains the same active peptide as Wegovy; it lacks the FDA manufacturing oversight of an approved product. Most serious safety incidents historically involved impure base peptides, not the compounded product from reputable 503A pharmacies.
Can semaglutide help with perimenopause weight gain?+–
Yes, it addresses the specific mechanisms perimenopause disrupts. Declining estrogen worsens insulin resistance, shifts fat toward the abdomen, and reduces the effectiveness of GLP-1 pathways that regulate appetite. Semaglutide improves insulin sensitivity, reduces appetite through GLP-1 receptor stimulation, and produces visceral fat reduction. Several clinicians now combine semaglutide with HRT to address both the hormonal cause and the metabolic consequence of the transition.
How do I get semaglutide for $25 a month?+–
The $25/mo price is the NovoCare savings card for commercially insured patients with Wegovy covered by their plan. The steps: confirm your commercial insurance covers Wegovy for obesity, get a prescription, fill at a NovoCare-participating pharmacy, and apply the savings card at the point of sale. If your insurance denies coverage, you may need to appeal with documentation of BMI and comorbidities. Cannot be used with Medicare or Medicaid.